Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center
NRG Oncology
Rise Therapeutics LLC
University of Virginia
Providence Health & Services
Revolution Medicines, Inc.